Document Detail


Combating malaria vectors in Africa: current directions of research.
MedLine Citation:
PMID:  12379942     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Vector control remains an important component of malaria control, particularly in Africa where most infant deaths occur. Among the different methods, insecticide-treated bednets seem to be a suitable way to reduce morbidity and child mortality in endemic areas. To facilitate their large-scale use and to investigate alternative vector control methods, the authors propose these current directions of research that are already being explored in Africa through a collaborating network involving several African countries: (1) vector genetics, (2) insecticide resistance and (3) vector control strategies.
Authors:
Jean-Marc Hougard; Didier Fontenille; Fabrice Chandre; Frédéric Darriet; Pierre Carnevale; Pierre Guillet
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Trends in parasitology     Volume:  18     ISSN:  1471-4922     ISO Abbreviation:  Trends Parasitol.     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-10-16     Completed Date:  2002-11-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  100966034     Medline TA:  Trends Parasitol     Country:  England    
Other Details:
Languages:  eng     Pagination:  283-6     Citation Subset:  IM    
Affiliation:
hougard@mpl.ird.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Africa
Animals
Anopheles / genetics,  growth & development*,  metabolism
Child, Preschool
Humans
Infant
Insect Vectors / genetics,  growth & development*,  metabolism
Insecticide Resistance / genetics
Malaria / prevention & control*
Plasmodium / growth & development*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anatomical informatics: Millennial perspectives on a newer frontier.
Next Document:  Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis?